Trial Profile
A Double Blind, Randomised, Three Way Crossover Study Comparing Two Different Sublingual Cannabis Based Medicine Extracts With Placebo, in Patients With Chronic Pain Due to Brachial Plexus Injury.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2023
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary) ; Nabiximols (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 18 Apr 2015 New trial record